Spinocerebellar ataxia type 3 (SCA3) can be present with a combination of cerebellar, neuropathic, pyramidal, or extrapyramidal symptoms. Tremor is a classical but not frequent manifestation of SCA3 and there is a lack of detailed knowledge regarding its origin. To study the clinical and electrophysiological characteristics of tremor in SCA3 patients, the authors conducted a case series of 72 SCA3 patients. Clinical characteristics of tremor and associated signs, response to treatments, follow-up, and genetic results were collected. Electrophysiological study including polymyographic recording was possible in 4/6 patients and DaTSCAN in 2/6. The authors also performed a systematic review of SCA3 cases with tremor (n = 36) reported previously in the literature. We identified two different tremor-types in 6/72 patients with SCA3 mutations, a "fast" (6.5-8 Hz) action, postural or tremor in orthostatism (initial symptom), which became slower over time with associated parkinsonism with a follow-up of 10 years and a "slow" rest, action and intention tremor (3-4 Hz) with distal and proximal component (including axial tremor in orthostatism). Total improvement of limbs and tremor in orthostatism was obtained with levodopa with occurrence of fluctuations/dyskinesia. Partial benefit was observed when additional signs were present (myoclunus/dystonia). The differences in tremor subtypes in SCA3 may be related to various combinations of mild to severe dysfunctions of the cerebello-thalamo-cortical loop and the nigro-striatal dopaminergic pathway.

Department of Neurology 1st Faculty of Medicine Charles University Prague and General University Hospital Prague Czech Republic

See more in PubMed

Mov Disord. 2009 Jul 30;24(10):1550-3 PubMed

Mov Disord. 2003 Feb;18(2):219-21 PubMed

J Neurol Sci. 2003 Sep 15;213(1-2):25-8 PubMed

Mov Disord. 2001 Nov;16(6):1133-6 PubMed

Mov Disord. 2009 Jan 15;24(1):144-7 PubMed

Arch Neurol. 1984 Aug;41(8):880-1 PubMed

Clin Neurol Neurosurg. 1999 Mar;101(1):56-61 PubMed

Mov Disord. 2004 Jul;19(7):788-795 PubMed

Neurology. 1998 Oct;51(4):1225-6 PubMed

Mov Disord. 2002 Nov;17(6):1350-3 PubMed

Mov Disord. 2007 Oct 31;22(14):2063-9 PubMed

J Neurol Neurosurg Psychiatry. 1982 Apr;45(4):372-4 PubMed

Mov Disord. 1996 Nov;11(6):741-3 PubMed

Neurology. 2006 Jun 13;66(11):1717-20 PubMed

J Neurol Neurosurg Psychiatry. 1999 Mar;66(3):278 PubMed

Parkinsonism Relat Disord. 2004 Aug;10(6):369-73 PubMed

Ann Neurol. 2011 Feb;69(2):269-81 PubMed

Arch Neurol. 2005 Aug;62(8):1280-5 PubMed

Ann Neurol. 1995 Oct;38(4):684-7 PubMed

Mov Disord. 2007 Oct 15;22(13):1971-4 PubMed

EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb. 1987 Mar;18(1):13-9 PubMed

Arch Neurol. 2001 Feb;58(2):296-9 PubMed

Eur Neurol. 2005;54(4):225-6 PubMed

Acta Neuropathol. 2008 Jan;115(1):71-86 PubMed

Mov Disord. 2008 Sep 15;23(12):1733-8 PubMed

J Neurol Neurosurg Psychiatry. 1999 May;66(5):681-4 PubMed

Curr Opin Neurol. 2008 Apr;21(2):111-6 PubMed

Muscle Nerve. 1993 Nov;16(11):1254-60 PubMed

Mov Disord. 1998;13 Suppl 3:2-23 PubMed

J Neurol Neurosurg Psychiatry. 2009 Jan;80(1):80-3 PubMed

J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1103-6 PubMed

Neurology. 2007 Jul 24;69(4):376-80 PubMed

Ann Neurol. 2001 Jun;49(6):805-7 PubMed

J Neurol Sci. 2009 Oct 15;285(1-2):121-4 PubMed

Brain. 2008 Oct;131(Pt 10):2701-9 PubMed

Cerebellum. 2008;7(2):125-37 PubMed

Postgrad Med J. 2004 Jun;80(944):363-5 PubMed

Parkinsonism Relat Disord. 2009 Jun;15(5):374-8 PubMed

Prog Biophys Mol Biol. 1995;64(2-3):237-78 PubMed

Arq Neuropsiquiatr. 2001 Sep;59(3-B):809-11 PubMed

J Neurol Sci. 2002 Oct 15;202(1-2):59-64 PubMed

Mov Disord. 2009 Oct 15;24(13):2007-11 PubMed

Lancet Neurol. 2010 Sep;9(9):885-94 PubMed

Mov Disord. 2011 Apr;26(5):792-800 PubMed

Acta Neurol Scand. 1999 Apr;99(4):241-4 PubMed

Acta Neurol Scand. 1989 Feb;79(2):119-22 PubMed